IP Library › Patent Application 16024203
Patent Application
App. No. 16/024,203

Isolated dsRNA Molecules And Methods Of Using Same For Silencing Target Molecules Of Interest

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/024,203
Abstract

An isolated dsRNA molecule comprising an antisense RNA sequence for regulating a target gene of interest in a plant or a phytopathogen of the plant, wherein the dsRNA sequence is flanked by two complementary sites to an smRNA or smRNAs expressed in the plant and wherein the dsRNA molecule further comprises a helicase binding site positioned so as to allow unwinding of the strands of the isolated dsRNA molecule to single stranded RNA (ssRNA) and recruitment of an RNA-dependent RNA polymerase so as to amplify the dsRNA molecule in the plant cell and generate secondary siRNA products of the dsRNA sequence.

Claims (63)

1 . An isolated double-stranded RNA (dsRNA) molecule comprising

(a) a first RNA strand having

at least one antisense RNA sequence for suppressing expression of a target gene of interest in a plant or a phytopathogen of a plant,

a first heterologous smRNA-binding sequence for binding to a first small RNA (smRNA) expressed in said plant or phytopathogen, and

a helicase-binding sequence comprising the helicase binding site of SEQ ID NO: 14; and

(b) a second RNA strand that is a reverse complement of said first RNA strand.

2 . The isolated dsRNA molecule of claim 1 , wherein said first smRNA comprises a nucleic acid sequence wherein said nucleic acid sequence shares between 100% and 90% sequence identity to a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1 to 288, and complements thereof.

3 .- 5 . (canceled)

6 . The isolated dsRNA molecule of claim 1 , wherein said first RNA strand further comprises a second heterologous smRNA-binding sequence for binding a second smRNA expressed in said plant or phytopathogen, and said first heterologous smRNA-binding sequence and said second heterologous smRNA-binding sequence flank said at least one antisense RNA sequence.

7 . The isolated dsRNA molecule of claim 6 , wherein said first smRNA and said second smRNA comprise a nucleic acid sequence having at least 90% sequence identity to a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1 to 288, and complements thereof.

8 . The isolated dsRNA molecule of claim 6 , wherein said second heterologous smRNA-binding sequence is the complement of said second smRNA.

9 . The isolated dsRNA molecule of claim 6 , wherein said second smRNA is identical to said first smRNA.

10 . The isolated dsRNA molecule of claim 6 , wherein said second smRNA is non-identical to said first smRNA.

11 . The isolated dsRNA molecule of claim 6 , wherein said first heterologous smRNA-binding sequence and said second heterologous smRNA-binding sequence comprise a nucleotide sequence selected from the group consisting of:

a direct sequence of said first smRNA and a direct sequence of said second smRNA;

a reverse complement of said first smRNA and a direct sequence of said second smRNA;

a reverse complement of said first smRNA and a reverse complement of said second smRNA;

a direct sequence of said first smRNA and a reverse complement of said second smRNA;

a direct sequence of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a direct sequence of said second smRNA;

a reverse complement of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a direct sequence of said second smRNA;

a reverse complement of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a reverse complement of said second smRNA;

a direct sequence of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a reverse complement of said second smRNA;

a direct sequence of said first smRNA and a direct sequence of said second smRNA and further comprising a mutation rendering it resistant to cleavage;

a reverse complement of said first smRNA and a direct sequence of said second smRNA and further comprising a mutation rendering it resistant to cleavage;

a reverse complement of said first smRNA and a reverse complement of said second smRNA and further comprising a mutation rendering it resistant to cleavage;

a direct sequence of said first smRNA and a reverse complement of said second smRNA and further comprising a mutation rendering it resistant to cleavage;

a direct sequence of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a direct sequence of said second smRNA and further comprising a mutation rendering it resistant to cleavage;

a reverse complement of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a direct sequence of said second smRNA and further comprising a mutation rendering it resistant to cleavage;

a reverse complement of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a reverse complement of said second smRNA and further comprising a mutation rendering it resistant to cleavage; and

a direct sequence of said first smRNA and further comprising a mutation rendering it resistant to cleavage and a reverse complement of said second smRNA and further comprising a mutation rendering it resistant to cleavage.

12 .- 14 . (canceled)

15 . The isolated dsRNA molecule of claim 1 , wherein said first smRNA has a nucleotide sequence selected from the group consisting of an RNA sequence of a microRNA (miRNA) and an RNA sequence of an siRNA.

16 . The isolated dsRNA molecule of claim 6 , wherein said first smRNA has a nucleotide sequence selected from the group consisting of an RNA sequence of a miRNA and an RNA sequence of an siRNA, and said second smRNA has a nucleotide sequence selected from the group consisting of an RNA sequence of a miRNA and an RNA sequence of an siRNA.

17 . (canceled)

18 . The isolated dsRNA molecule of claim 1 , wherein said first smRNA is a miRNA.

19 . The isolated dsRNA molecule of claim 6 , wherein said first smRNA is a miRNA and said second smRNA is a miRNA.

20 . (canceled)

21 . The isolated dsRNA molecule of claim 1 , wherein said first smRNA is a miRNA selected from the group consisting of miR390, miR161.1, miR168, miR393, miR828, and miR173.

22 . The isolated dsRNA molecule of claim 6 , wherein said first smRNA is a miRNA selected from the group consisting of miR390, miR161.1, miR168, miR393, miR828, and miR173.

23 .- 48 . (canceled)

49 . A method of suppressing gene expression in a plant or a phytopathogen of the plant comprising:

a. contacting a seed with an isolated double-stranded RNA (dsRNA) molecule of claim 1 under conditions which allow penetration of said dsRNA molecule into said seed,

thereby introducing said dsRNA molecule into said seed; and optionally

b. generating a plant of said seed.

50 . The method of claim 49 , wherein said dsRNA molecule penetrates a cell of said seed selected from the group consisting of an endosperm cell, an embryo cell, and combinations thereof.

51 .- 69 . (canceled)

70 . An isolated double-stranded RNA (dsRNA) molecule comprising:

a first RNA strand having a nucleic acid sequence comprising in a sequential order from 5′ to 3′;

an endovirus 5′ UTR sequence;

an endovirus RNA Dependent RNA Polymerase (RDRP) coding sequence;

a multiple cloning site;

an endovirus 3′ UTR sequence; and

a second RNA strand that is a reverse complement of said first RNA strand.

71 . An isolated dsRNA molecule comprising:

a first RNA strand having a nucleic acid sequence comprising in a sequential order from 5′ to 3′;

an endovirus 5′ untranslated region (UTR) sequence;

an endovirus RNA Dependent RNA Polymerase (RDRP) coding sequence;

an antisense nucleic acid sequence for regulating a target gene;

an endovirus 3′ UTR sequence; and

a second RNA strand that is a reverse complement of said first RNA strand.

72 . The isolated dsRNA molecule of claim 70 , wherein said endovirus 5′ UTR sequence, said endovirus RNA Dependent RNA Polymerase (RDRP) coding sequence and said endovirus 3′ UTR sequence are capable of autonomous replication when introduced into a plant cell.

73 . The isolated dsRNA molecule of claim 71 , wherein said endovirus 5′ UTR sequence, said endovirus RNA Dependent RNA Polymerase (RDRP) coding sequence and said endovirus 3′ UTR sequence are capable of autonomous replication when introduced into a plant cell.

74 .- 113 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: A.B. SEEDS LTD.
To: MONSANTO TECHNOLOGY LLC
Reel/Frame 051845/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2018
From: AVNIEL, AMIR; LIDOR-NILI, EFRAT; MAOR, RUDY; MEIR, OFIR; NOIVIRT-BRIK, ORLY; YANAI-AZULAY, OSNAT
To: A.B. SEEDS LTD.
Reel/Frame 047109/0156 →